• 0 items in quote

    No products in the Quote Basket.

  • mavenclad (cladribine) 10mg tablet

    Quantity

    Get Price

    Get it to Germany within 10 working days with standard delivery.

    Fast delivery to Germany

    Easy Returns & Exchanges

    Ask About This Product

    Condition : New

    0

    From UAE

    To Germany

    in 5-10 days

    Description

    Mavenclad (cladribine) 10mg tablets are an oral medication prescribed primarily for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It is intended for patients who have tried other treatments without sufficient success or who have difficulty with injectable therapies. Mavenclad is unique in its use of selective immune reconstitution therapy (SIRT), which targets specific immune cells thought to play a role in MS.

    How Mavenclad Works

    Cladribine, the active ingredient in Mavenclad, is a purine analog that selectively targets and reduces specific white blood cells, namely lymphocytes (B and T cells), which are part of the immune system. In multiple sclerosis, the immune system attacks the protective myelin sheath surrounding nerve cells. By targeting and reducing certain lymphocytes, Mavenclad helps to suppress the immune system’s attack on the nervous system. The therapy is designed to be taken in two annual treatment courses, each lasting a few days, with no further dosing needed between the treatment cycles. This approach offers patients long-lasting results with a relatively low treatment burden.

    Indications

    Mavenclad is approved for use in the following cases:
    • Relapsing-Remitting Multiple Sclerosis (RRMS): Used to reduce the frequency of relapses in adults with RRMS.
    • Active Secondary Progressive Multiple Sclerosis (SPMS): Helps slow disease progression in SPMS with relapses.

    Side Effects

    Common side effects of Mavenclad include:
    • Headache
    • Cold-like symptoms (e.g., sore throat, congestion)
    • Lowered lymphocyte counts
    • Rash or skin irritation
    • Nausea
    Serious side effects can include:
    • Increased risk of infections (e.g., herpes zoster)
    • Liver function abnormalities
    • Bone marrow suppression
    • Risk of developing malignancies

    Contraindications

    Mavenclad should not be used in the following cases:
    • Pregnancy: Contraindicated due to risk of fetal harm.
    • Active Infection: Not for use in individuals with active chronic infections.
    • Cancer: Contraindicated in patients with current or recent history of malignancy.
    • HIV Infection: Not for use in patients with HIV due to immunosuppressive effects.
    • Allergy to Cladribine: Not for use in patients with known hypersensitivity to cladribine.

    Price of Mavenclad in Different Countries

    The table below provides approximate pricing for Mavenclad (cladribine) 10mg tablets in various countries. Prices may vary depending on the pharmacy, insurance coverage, and local regulations.
    Country Price (per tablet) Source
    United States $200 – $250 GoodRx
    Canada CAD 230 – CAD 280 PharmacyChecker
    United Kingdom £180 – £220 NHS UK
    Australia AUD 300 – AUD 350 PBS Australia
    India INR 15,000 – INR 18,000 1mg India

    Top 5 Global Brands for Cladribine-based MS Therapy

    • Mavenclad (EMD Serono) – A widely available brand for treating relapsing MS.
    • Cladopa (Bavarian Nordic) – Known for cladribine therapy for specific MS cases.
    • Cladribine Tablets (Various generics) – Several manufacturers produce cladribine tablets, primarily for MS treatments.
    • Cladrix (Regen Biopharma) – Another cladribine-based option aimed at immune modulation.
    • NODAX (Teva Pharmaceuticals) – Known in some regions as a cladribine-based therapy for MS patients.
     
    Shopping Cart
    mavenclad (cladribine) 10mg tablet
    Get Price